New Products

• 2763914-21-0 Antitumor agent-49

• 2948338-60-9 Anticancer agent 142

• 2765579-76-6 (R)-Monlunabant

• 2925547-95-9 USP1-IN-6

• 3010873-44-3 Tyk2-IN-15

• 2247025-63-2 ST8155AA1

• 2560577-69-5 Sontigidomide

• 3023471-40-8 SIRT6-IN-3

• 78471-90-6 SARS-CoV-2-IN-69

• 2918815-34-4 PRMT5-IN-32

• 2919684-77-6 PI3K/mTOR Inhibitor-14

• 2173201-65-3 PAR4 antagonist 1

• 3031654-46-0 NC-III-49-1

• 2604667-43-6 Myrrhterpenoid O

• 1609108-96-4 MC-VC-PAB-Cyclohexanediamine-Thailanstatin A

• 2757469-20-6 Immuno modulator-1

• 1313602-87-7 ICMT-IN-37

• 1313603-17-6 ICMT-IN-32

• 1313602-97-9 ICMT-IN-14

• 2912457-83-9 HSD17B13-IN-67

• 1448355-15-4 HL23

• 2414055-95-9 hERG-IN-2

• 2995354-52-2 HDAC-IN-71

• 1967002-25-0 HBV-IN-41

• 1384951-03-4 GPR119 agonist 2

• 2841688-66-0 GGFG-Eribulin

• 1448523-50-9 FIKK9.1-IN-1

• 1970120-44-5 FGFR4-IN-16

• 2639168-13-9 Estrogen receptor modulator 7

• 1449373-99-2 DQP-26

• 2941512-38-3 DosatiLink-2

• 2581994-88-7 c-Myc inhibitor 14

• 2894104-40-4 CDD-1819

• 2815225-15-9 Cbl-b-IN-11

• 2377392-07-7 Arginase inhibitor 7

• 2873460-31-0 7Ethanol-10NH2-11F-Camptothecin

• 2151881-74-0 SIQ17

• 868860-35-9 RSV L-protein-IN-3

• 2561431-77-2 RIPK1-IN-16

• 2583767-68-2 RET-IN-24

• 1253647-46-9 rel-(2S,3R)-Voruciclib hydrochloride

• 2923520-98-1 RE-33

• 2839429-51-3 RDN2150

• 2242788-69-6 PRMT5-IN-29

• 2944101-99-7 PARP1/c-Met-IN-1

• 2890760-43-5 OSBP-IN-1

• 2854331-14-7 NK3R-IN-1

• 1843236-92-9 Mn007

• 2490543-89-8 MMP-9-IN-8

• 2679821-44-2 Mal-PEG8-Phe-Lys-PAB-Exatecan

• 2252448-93-2 Kv2.1-IN-1

• 1313602-74-2 ICMT-IN-4

• 1313602-99-1 ICMT-IN-17

• 2770247-73-7 HSD17B13-IN-84

• 2770247-59-9 HSD17B13-IN-65

• 2770246-81-4 HSD17B13-IN-53

• 2758802-19-4 HSD17B13-IN-23

• 2848684-50-2 HPK1-IN-42

• 2925381-27-5 HIV-1 protease-IN-9

• 3030872-95-5 HDAC6-IN-38

• 2923907-92-8 GLI1-IN-1

• 2363715-13-1 GABA-IN-2

• 2738583-25-8 Enpp-1-IN-19

• 3020681-05-1 EGFR-IN-97

• 311334-13-1 Cyclohexyl [3,5-bis(methylthio)-4-isothiazolyl]carbamate

• 2727083-99-8 CXF-007

• 2815221-33-9 Cbl-b-IN-6

• 2631005-84-8 Cap-dependent endonuclease-IN-9

• 2812356-72-0 Antitumor agent-73

• 2761736-66-5 Anticancer agent 162

• 2941243-62-3 Anticancer agent 128

• 1448808-50-1 5-HT7R antagonist 2

• 1178895-15-2 22-(4′-py)-JA

• 2757301-90-7 (S)-(-)-MRJF22

• 2845164-91-0 Val-Ala-PABC-Exatecan

• 2925298-08-2 SB-1436

• 2653349-51-8 S16–1029

• 2941484-13-3 RXFP1 receptor agonist-7

• 2763831-43-0 RIPK1-IN-19

• 2565638-16-4 PolQi2

• 2893920-80-2 PI3Kα-IN-15

• 2883747-74-6 p-fin4

• 2765304-82-1 NMS-0963

• 2769040-08-4 NLRP3-IN-31

• 2757277-32-8 N3-PEG3-VC-PAB-MMAF

• 2965311-25-3 METTL3-IN-5

• 2238820-43-2 JT002

• 2427608-43-1 JAK1-IN-11

• 1313602-72-0 ICMT-IN-47

• 1313602-67-3 ICMT-IN-42

• 1313603-13-2 ICMT-IN-29

• 2848620-90-4 HSD17B13-IN-94

• 2576696-34-7 HSD17B13-IN-6

• 2758802-03-6 HSD17B13-IN-11

• 2944459-43-0 HDAC-IN-59

• 2592436-21-8 GRK2 Inhibitor 2

• 3006105-44-5 GPR55 agonist 3

• 2757214-13-2 Glabrescone C

• 2423992-72-5 FXIa-IN-14

• 2761152-16-1 FHND5071